Methotrexate-loaded tumour-cell-derived microvesicles can relieve biliary obstruction in patients with extrahepatic cholangiocarcinoma

Y Gao, H Zhang, N Zhou, P Xu, J Wang… - Nature biomedical …, 2020 - nature.com
Most patients with cholangiocarcinoma (CCA) develop extrahepatic malignant biliary
obstructions, which require palliative drainage to normalize bilirubin levels and to improve …

Methotrexate-loaded tumour-cell-derived microvesicles can relieve biliary obstruction in patients with extrahepatic cholangiocarcinoma

Y Gao, H Zhang, N Zhou, P Xu… - Nature biomedical …, 2020 - pubmed.ncbi.nlm.nih.gov
Most patients with cholangiocarcinoma (CCA) develop extrahepatic malignant biliary
obstructions, which require palliative drainage to normalize bilirubin levels and to improve …

Methotrexate-loaded tumour-cell-derived microvesicles can relieve biliary obstruction in patients with extrahepatic cholangiocarcinoma.

Y Gao, H Zhang, N Zhou, P Xu, J Wang… - Nature Biomedical …, 2020 - europepmc.org
Most patients with cholangiocarcinoma (CCA) develop extrahepatic malignant biliary
obstructions, which require palliative drainage to normalize bilirubin levels and to improve …

Methotrexate-loaded tumour-cell-derived microvesicles can relieve biliary obstruction in patients with extrahepatic cholangiocarcinoma

G Yunfeng, H Zhang, Z Nannan… - Nature Biomedical …, 2020 - search.proquest.com
Most patients with cholangiocarcinoma (CCA) develop extrahepatic malignant biliary
obstructions, which require palliative drainage to normalize bilirubin levels and to improve …